• Je něco špatně v tomto záznamu ?

New role for crinamine as a potent, safe and selective inhibitor of human monoamine oxidase B: In vitro and in silico pharmacology and modeling

D. Naidoo, A. Roy, LP. Slavětínská, JC. Chukwujekwu, S. Gupta, J. Van Staden,

. 2020 ; 248 (-) : 112305. [pub] 20191019

Jazyk angličtina Země Irsko

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023171

ETHNOPHARMACOLOGICAL RELEVANCE: The development of selective inhibitors of monoamine oxidase B (MAO-B) has been essential in treating Parkinson's disease. However, the apparent hepatotoxicity and drug-drug interactions of current inhibitors accentuate the need for the development of novel pharmacotherapies. Crossyne guttata (L.) D. & U. Müll-Doblies is used frequently by Rastafarian bush doctors to treat alcoholism, a disorder which is also accentuated by MAO. OBJECTIVE: The study sought to isolate, identify and characterise the biologically active constituents of C. guttata based on their ability to inhibit the MAO enzymes. MATERIALS AND METHODS: Column chromatography was used to isolate the biologically active alkaloids of C. guttata. The ability of the alkaloids to inhibit the biotransformation of 4-aminoantipyrine by the MAO enzymes was evaluated in vitro. In silico docking was conducted using AutoDock Vina server while the pharmacokinetic properties of the compounds were evaluated using SwissADME. RESULTS: Chromatographic separation of an ethanolic fraction of C. guttata yielded the alkaloids crinamine 1 and epibuphanisine 2. 1 and 2 along with structurally related alkaloids haemanthamine 3 and haemanthidine 4 were evaluated for their ability to inhibit the action of isozymes of MAO in vitro. Alkaloids effected submicromolar IC50 values against MAO-B, the most potent of which being crinamine 1 (0.014 μM) > haemanthidine 4 (0.017 μM) > epibuphanisine 2 (0.039 μM) > haemanthamine 3 (0.112 μM). Binding energies of the alkaloids correlated well with their inhibitory potential with crinamine displaying the best binding efficacy and binding energy score with MAO-B. DISCUSSION AND CONCLUSION: Crinamine and epibuphanisine exhibited potent and selective inhibitory activity towards MAO-B. After comprehensive in silico investigations encompassing robust molecular docking analysis, the drug-like attributes and safety of the alkaloids suggest the crinamine is a potentially safe drug for human application.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023171
003      
CZ-PrNML
005      
20201214125416.0
007      
ta
008      
201125s2020 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jep.2019.112305 $2 doi
035    __
$a (PubMed)31639490
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Naidoo, D $u Research Centre for Plant Growth and Development, School of Life Sciences, University of KwaZulu-Natal Pietermaritzburg, Private Bag X01, Scottsville 3209, South Africa.
245    10
$a New role for crinamine as a potent, safe and selective inhibitor of human monoamine oxidase B: In vitro and in silico pharmacology and modeling / $c D. Naidoo, A. Roy, LP. Slavětínská, JC. Chukwujekwu, S. Gupta, J. Van Staden,
520    9_
$a ETHNOPHARMACOLOGICAL RELEVANCE: The development of selective inhibitors of monoamine oxidase B (MAO-B) has been essential in treating Parkinson's disease. However, the apparent hepatotoxicity and drug-drug interactions of current inhibitors accentuate the need for the development of novel pharmacotherapies. Crossyne guttata (L.) D. & U. Müll-Doblies is used frequently by Rastafarian bush doctors to treat alcoholism, a disorder which is also accentuated by MAO. OBJECTIVE: The study sought to isolate, identify and characterise the biologically active constituents of C. guttata based on their ability to inhibit the MAO enzymes. MATERIALS AND METHODS: Column chromatography was used to isolate the biologically active alkaloids of C. guttata. The ability of the alkaloids to inhibit the biotransformation of 4-aminoantipyrine by the MAO enzymes was evaluated in vitro. In silico docking was conducted using AutoDock Vina server while the pharmacokinetic properties of the compounds were evaluated using SwissADME. RESULTS: Chromatographic separation of an ethanolic fraction of C. guttata yielded the alkaloids crinamine 1 and epibuphanisine 2. 1 and 2 along with structurally related alkaloids haemanthamine 3 and haemanthidine 4 were evaluated for their ability to inhibit the action of isozymes of MAO in vitro. Alkaloids effected submicromolar IC50 values against MAO-B, the most potent of which being crinamine 1 (0.014 μM) > haemanthidine 4 (0.017 μM) > epibuphanisine 2 (0.039 μM) > haemanthamine 3 (0.112 μM). Binding energies of the alkaloids correlated well with their inhibitory potential with crinamine displaying the best binding efficacy and binding energy score with MAO-B. DISCUSSION AND CONCLUSION: Crinamine and epibuphanisine exhibited potent and selective inhibitory activity towards MAO-B. After comprehensive in silico investigations encompassing robust molecular docking analysis, the drug-like attributes and safety of the alkaloids suggest the crinamine is a potentially safe drug for human application.
650    _2
$a alkaloidy amarylkovitých $x chemie $x farmakokinetika $x farmakologie $x toxicita $7 D047151
650    _2
$a zvířata $7 D000818
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a Cercopithecus aethiops $7 D002522
650    _2
$a lidé $7 D006801
650    12
$a biologické modely $7 D008954
650    12
$a simulace molekulového dockingu $7 D062105
650    _2
$a monoaminoxidasa $x chemie $x metabolismus $7 D008995
650    _2
$a inhibitory MAO $x chemie $x farmakokinetika $x farmakologie $x toxicita $7 D008996
650    _2
$a mutace $7 D009154
650    _2
$a bezpečnost pacientů $7 D061214
650    _2
$a konformace proteinů $7 D011487
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a Salmonella typhimurium $x účinky léků $x genetika $7 D012486
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a Vero buňky $7 D014709
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Roy, A $u Research Centre for Plant Growth and Development, School of Life Sciences, University of KwaZulu-Natal Pietermaritzburg, Private Bag X01, Scottsville 3209, South Africa.
700    1_
$a Slavětínská, L Poštová $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo Nám. 2, 16610 Prague-6, Czech Republic.
700    1_
$a Chukwujekwu, J C $u Research Centre for Plant Growth and Development, School of Life Sciences, University of KwaZulu-Natal Pietermaritzburg, Private Bag X01, Scottsville 3209, South Africa.
700    1_
$a Gupta, S $u Research Centre for Plant Growth and Development, School of Life Sciences, University of KwaZulu-Natal Pietermaritzburg, Private Bag X01, Scottsville 3209, South Africa.
700    1_
$a Van Staden, J $u Research Centre for Plant Growth and Development, School of Life Sciences, University of KwaZulu-Natal Pietermaritzburg, Private Bag X01, Scottsville 3209, South Africa. Electronic address: rcpgd@ukzn.ac.za.
773    0_
$w MED00006644 $t Journal of ethnopharmacology $x 1872-7573 $g Roč. 248, č. - (2020), s. 112305
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31639490 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125415 $b ABA008
999    __
$a ok $b bmc $g 1595490 $s 1113847
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 248 $c - $d 112305 $e 20191019 $i 1872-7573 $m Journal of ethnopharmacology $n J Ethnopharmacol $x MED00006644
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace